New $5.8 million grant aims to transform the global landscape of TB research

A $5.8 million grant led by Adrie Steyn, Ph.D., of the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.

Autolus eyes November for potential US approval of Tecartus rival

Autolus Therapeutics is expecting an FDA decision on Nov. 16 for obecabtagene autoleucel (obe-cel), its CAR-T hopeful that would rival Gilead’s Tecartus in adult acute

January 23, 2024

Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions – Pharmaceutical Technology

The biopharma company has filed a comprehensive patent to address cystic fibrosis and other ailments. Image Credit: Zerbor/Shutterstock Porosome Therapeutics has announced a potentially novel

August 22, 2023

Study uncovers thousands of medication pairings linked to frequent dosage adjustments

Researchers investigated the complexity of polypharmacy and whether frequent dose adjustments were required for co-medications and drug pairs in hospital settings.

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.